ArticleClinical kidney journal2026

Efficacy and safety of dapagliflozin in patients receiving dialysis: a post-hoc analysis of the DAPA-CKD trial.

Wisanne M Bakker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.